Semaglutide
STEP-HFpEF
Novo Nordisk · Phase 3 · Completed · Enrollment 529
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Semaglutide | n/r | n/r | n/r | n/r | n/r |
| Placebo (semaglutide) | 7 participants | 3 participants | 10 participants | n/r | 4 |
A count stays a count. This page does not turn a count into a percent.